Loading
Convatec Group Plc Stock: price and insider trades · United Kingdom
2 insiders bought €330k of shares over the last 90 days, the latest filed 14 Oct 2026.
Convatec Group Plc: what insiders have been doing
Headquartered in Reading, United Kingdom, Convatec Group Plc is a listed company and traces its origins to 1978. Filings by its managers are published through RNS (LSE). The last twelve months, up to 18 October 2026, brought 8 filings signed by 4 insiders.
Open-market activity splits into 4 purchases totalling €372k and 2 sales; 4 insiders sit on the buying side and 2 insiders on the selling side. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €132k, bought by Tobias Hestler and made public on 7 August 2026 (0.0028% of market cap). Among those who bought: 2 board members, 1 finance chief and 1 chief executive.
With 8 filings in twelve months, the company is more active than the median of 6 filings across the 833 companies we follow on the same exchange. Looking back to 2023, when coverage begins, insiders filed 7 purchases and 6 sales.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 14 October 2026, 4 days ago. Filings reach the RNS (LSE) feed a median of 1 day after the trade. For comparison, UK MAR gives managers three business days to notify a trade.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Insider Decl.
28
Thresholds
n/a
Buy Volume
€576,732
7 ops. · all time
Sell Volume
€11M
6 ops. · all time
Who traded when
BuySaleJonny Mason3 buys2 sales
Fiona Ryder3 buys1 sale
Karim Bitar3 sales
Tobias Hestler2 buys
Jens Viebke1 buy
Since the insiders bought
- -1.2%Entry £2.34 · Close 13 Oct 2026 £2.31
- +14.1%Entry £2.02 · Close 13 Oct 2026 £2.31
- +14.1%Entry £2.02 · Close 13 Oct 2026 £2.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Convatec Group Plc Strong Buy (bullish), based on 19 analysts. Average price target: £3.05.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,078 of 24,148 companies
57.7
score / 100
Value59
Quality57
FCF yld6.3%
Earn yld3.9%
EV/EBITDA11.7x
ROE7.7%
Gross mgn56%
Net mgn7.2%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
£2.31
Analyst consensus
19 analystsStrong buy
£2.30Target £3.05(+32%)£3.75
Income statement
Revenue£2.4B
Gross profit£1.4B56% margin
EBITDA£516M21% margin
Net income£175M5.0% margin
Valuation
PER (trailing)46.1x
PER (forward)1005.5x
P/Book417.2x
Beta0.77
Balance sheet & cash
Market cap£4.4B
Total debt£1.5B
Free Cash Flow£285M
Debt / Equity122%
Profitability & ownership
ROE7.7%
ROA6.7%
% insiders0.2%
% institutions86.1%
Last declaration on 14 October 2026
Declarations28 total
24,400 shares@ £2.298XLONISIN GB00BD3VFW73RNS:9822759
Canonical exit: 11 Jan 2027 (T+90)
50,000 shares@ £2.2580.0028% mcap100.0% of flowXLONISIN GB00BD3VFW73RNS:9710703
Canonical exit: 4 Nov 2026 (T+90)
50,000 shares@ £2.01174.5% of flowXLONRNS:10736f1b-3582-4ecd-8ad5-92835553fb87-0
Canonical exit: 24 Aug 2026 (T+90)
24,993 shares@ £2.000773.2% of flowXLONRNS:10736f1b-3582-4ecd-8ad5-92835553fb87-1
Canonical exit: 24 Aug 2026 (T+90)
0XLONRNS:39dc3deb-c8f2-4542-b4f5-c35eb633b6ce-0
0XLONRNS:39dc3deb-c8f2-4542-b4f5-c35eb633b6ce-1
0Outside a trading venueRNS:741eb137-a8e5-4d5e-9b38-009e62cbb391-0
0Outside a trading venueRNS:741eb137-a8e5-4d5e-9b38-009e62cbb391-1
3,200 shares0Outside a trading venueRNS:5850004
9,340 shares@ £1.96460.8% of flowOutside a trading venueRNS:5817803-0
9,340 shares@ £1.964626.8% of flowOutside a trading venueRNS:5817803-1
20,692 shares@ £1.73971.6% of flowOutside a trading venueISIN GB00BD3VFW73FCA-NSM:5812134-0
10,253 shares@ £1.75550.2% of flowOutside a trading venueISIN GB00BD3VFW73FCA-NSM:5812134-1
10,346 shares@ £1.739713.2% of flowOutside a trading venueISIN GB00BD3VFW73FCA-NSM:5808410
21,263 shares@ £2.339636.6% of flowLondon Stock ExchangeISIN GB00BD3VFW73FCA-NSM:5799727-1
Canonical exit: 26 Nov 2025 (T+90)
50,000 shares@ £2.34815.2% of flowLondon Stock ExchangeRNS:5799727-0
Canonical exit: 26 Nov 2025 (T+90)
1,250,000 shares@ £2.26537.6% of flowLondon Stock ExchangeRNS:5772458
150,434 shares0Outside a trading venueRNS:5678249-1
831,126 shares0Outside a trading venueRNS:5678249-0
756,146 shares@ £2.599589.5% of flowLondon Stock ExchangeRNS:5579384
412,868 shares@ £2.561214.5% of flowLondon Stock ExchangeRNS:5579350-1
1,363,267 shares@ £2.561247.9% of flowLondon Stock ExchangeRNS:5579350-0
1,108,169 shares0Outside a trading venueRNS:5571410-0
501,448 shares0Outside a trading venueRNS:5571410-1
242,935 shares0Outside a trading venueRNS:5571410-2
25 of 28 declarations
About Convatec Group Plc
Convatec Group Plc is a medical products company that provides solutions for wound care, continence, and stoma care. It is listed on the London Stock Exchange under the ticker XLON.
